reference/32276184

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32276184

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	2072
issn	0007-1188
issueIdentifier	8
pageRange	2064-2072
publicationName	British Journal of Pharmacology
startingPage	2064
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e423e98d115894f5b30465dcb1113e0c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0d28c78b9972d259b73e1725017f7f80 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1ca4756a3aff6c9d047b432e74f35021 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9db9faf4b5ed1f7db05eb327bcb48cec http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7dc29a07ce54c8aff05b8284aa63ea29
bibliographicCitation	Yu L, Jin X, Yang Y, Cui N, Jiang C. Rosiglitazone inhibits vascular KATP channels and coronary vasodilation produced by isoprenaline. Br J Pharmacol. 2011 Dec;164(8):2064–72. PMID: 21671900; PMCID: PMC3246668.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd5d532cf229e3cdf0780a361c1093ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6417-3654 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b1324c2a3eb2f7786d0b93f2a0c6c80 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_111b304301a60742a858f509358493df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da4a716110559e85b86dc39d59b12b29 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4275-0515 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
date	2011-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/21671900 https://pubmed.ncbi.nlm.nih.gov/PMC3246668 https://doi.org/10.1111/j.1476-5381.2011.01539.x
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1895 https://portal.issn.org/resource/ISSN/0007-1188
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Rosiglitazone inhibits vascular KATP channels and coronary vasodilation produced by isoprenaline
discusses	http://id.nlm.nih.gov/mesh/M0237199 http://id.nlm.nih.gov/mesh/M0022559 http://id.nlm.nih.gov/mesh/M0010903 http://id.nlm.nih.gov/mesh/M0447306 http://id.nlm.nih.gov/mesh/M0011781
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014665Q000494 http://id.nlm.nih.gov/mesh/D003331Q000187 http://id.nlm.nih.gov/mesh/D007545Q000494 http://id.nlm.nih.gov/mesh/D007004Q000494 http://id.nlm.nih.gov/mesh/D045162Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000077154 http://id.nlm.nih.gov/mesh/D018408 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D002460
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3779 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8179 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_201c64e56691150496e935432e20402f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3488 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77999

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129308074 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128339775 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129928295 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127863084 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433

Total number of triples: 61.